›› 2014, Vol. 29 ›› Issue (11): 1141-1143.DOI: 10.3969/j.issn.1673-8640.2014.11.015

• Orignal Article • Previous Articles     Next Articles

Clinical distribution and drug resistance analysis for 63 isolates of Stenotrophomonas maltophilia

XU Fei, LIU Xuemei, CHI Fuli, TAN Hua, CHANG Yong, CAO Bo   

  1. Department of Clinical Laboratory, the Children's Hospital Affiliated to Nanjing Medical University, Jiangsu Nanjing 210008, China
  • Received:2014-07-15 Online:2014-11-01 Published:2014-11-28

Abstract:

Objective To investigate the clinical distribution and drug resistance of Stenotrophomonas maltophilia. Methods The clinical distribution and drug resistance analysis for 63 isolates of Stenotrophomonas maltophilia(K-B) method. The results were analyzed statistically. Results The isolation rate was the highest in respiratory specimens . There was a highest isolation rate of 87.3%. The samples were mainly obtained from the wards of Neonatology Department(17.4%) and Thoracic Surgery(17.4%), followed by Respiratory Department(4.3%) and Intensive Care Unit(ICU)(14.3%). The 63 isolates of Stenotrophomonas maltophilia, and the resistance rate was 100.0%. The resistance rates to levofloxacin, minocyline and triethoprim-sulfamethoxazole were 1.6%, 3.2% and 3.2%. Conclusions It should enhance drug resistance monitoring of Stenotrophomonas maltophilia. Treatment based on drug susceptibility test should be adapted as soon as possible. were highly resistant to imipenem were performed by VITEK-2 COMPACT system and Kirby-Bauer.

Key words: Stenotrophomonas maltophilia, Drug resistance, Antibiotic

CLC Number: